EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evidence for early, clinically silent medial temporal lobe inflammation after CAR-T cell therapy

Marwa Al Dubai, Mahima Verginia Rebello, Katja Neumann, Mirjeta Berisha, Dimitrios Katsaros, Tobias Ronny Haage, Denise Walther, Jörn Kaufmann, Stephan Fricke, Daniel Uher, Oliver Speck, Johanna Engel und 7 weitere

European Journal of Cancer · 2026-08 · 244 · 116925

DOI: 10.1016/j.ejca.2026.116925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-08. Verfasst von Marwa Al Dubai und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Otto von Guericke University, Magdeburg, Germany. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Temporal Lobe, Neurotoxicity Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Immune effector cell-associated neurotoxicity syndrome (ICANS) is the most frequent neurological complication following chimeric antigen receptor (CAR)-T cell therapy. Long-term cognitive effects remain controversial, even in the absence of clinical neurotoxicity. CAR-T cell-associated neurotoxicity often involves the medial temporal lobe (MTL), yet conventional structural magnetic resonance imaging (MRI) frequently remains normal. There is a need for markers of subclinical neurotoxicity that may predict long-term cognitive outcomes. METHODS: Therefore, we established an imaging protocol integrating 3 Tesla (T) and 7 T perfusion and functional connectivity MRI of the MTL in patients receiving CAR-T cells for B cell malignancies. Longitudinal data from four patients is presented here. RESULTS: Two of the four patients developed ICANS (grade 1 and grade 3), and these patients also experienced mild cytokine release syndrome (CRS, grade 1). No structural abnormalities of the MTL were detected at baseline or during follow-up. CAR-T cell expansion varied markedly between patients. Regardless of ICANS, CRS, or CAR-T cell expansion, patients showed increased MTL perfusion and functional connectivity, most prominently at days 10-14. CONCLUSION: These data suggest an early, clinically silent inflammatory response in the MTL with potential implications for long-term cognitive function, which requires further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveTemporal LobeNeurotoxicity SyndromesHumansFemaleMagnetic Resonance ImagingMaleMiddle AgedReceptors, Chimeric AntigenAdult

Stichwörter der Autor:innen

CAR-T cell therapyICANSMRINeurotoxicityToxicity

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Neurology, Otto von Guericke University, Magdeburg, Germany.
  • Department of Hematology, Oncology, Cell Therapy, and Radiation Therapy, Otto von Guericke University, Magdeburg, Germany.
  • Institute for Clinical Immunology and Cell Therapeutics, Otto von Guericke University, Magdeburg, Germany; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Magdeburg Center for Cell and Immune The…
  • Biomedical Magnetic Resonance, Faculty of Natural Sciences, Otto von Guericke University, Magdeburg, Germany.
  • Biomedical Magnetic Resonance, Faculty of Natural Sciences, Otto von Guericke University, Magdeburg, Germany; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany; Center for Behavioral Brain Sciences…
  • Department of Neurology, University Hospital Muenster, Muenster, Germany.

Förderung

  • German Research Foundation
  • European Regional Development Fund

Zitieren

APA

Dubai, M. A., Rebello, M. V., Neumann, K., Berisha, M., Katsaros, D., Haage, T. R., Walther, D., Kaufmann, J., Fricke, S., Uher, D., Speck, O., Engel, J., Meuth, S. G., Melekh, B., Behme, D., Mattern, H., Henneicke, S., Schreiber, S., & Mougiakakos, D. (2026). Evidence for early, clinically silent medial temporal lobe inflammation after CAR-T cell therapy. European Journal of Cancer, 244, 116925. https://doi.org/10.1016/j.ejca.2026.116925

Vancouver

Dubai MA, Rebello MV, Neumann K, Berisha M, Katsaros D, Haage TR, et al. Evidence for early, clinically silent medial temporal lobe inflammation after CAR-T cell therapy. European Journal of Cancer. 2026;244:116925. doi:10.1016/j.ejca.2026.116925

BibTeX
@article{Dubai2026,
  author = {Dubai, Marwa Al and Rebello, Mahima Verginia and Neumann, Katja and Berisha, Mirjeta and Katsaros, Dimitrios and Haage, Tobias Ronny and Walther, Denise and Kaufmann, Jörn and Fricke, Stephan and Uher, Daniel and Speck, Oliver and Engel, Johanna and Meuth, Sven G and Melekh, Bohdan and Behme, Daniel and Mattern, Hendrik and Henneicke, Solveig and Schreiber, Stefanie and Mougiakakos, Dimitrios},
  title = {Evidence for early, clinically silent medial temporal lobe inflammation after CAR-T cell therapy},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {244},
  pages = {116925},
  doi = {10.1016/j.ejca.2026.116925}
}
Kostenlos starten →